Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
et al: Drug repurposing of FDA compounds against -Glucosidase for the treatment of type 2 diabetes: insights from molecular docking and molecular dynamics simulations
extend our understanding of the mechanism of action of metformin and provide further insights into the benefits of combining metformin with incretin-based drugs to combat diabetes
May Children Use Our Website
For pharma manufacturers, the sudden popularity of GLP-1 drugs has placed increased strain on the medical supply chain and subsequent pressure to avoid bottle necks
US$ 28.58
US$ 26.72
US$ 24.07
